A Rare Case Presentation on Inflammatory Myofibroblastic Tumour of the Stomach

An Inflammatory Myofibroblastic Tumour (IMT) is a rare disease entity. The IMT was first observed in pulmonary site. The IMT can involve any site of the body and the most common site are lung, liver and gastrointestinal tract. . It usually develops in children or young adults, but can affect people of any age. Clinically the IMTs are painless indurated mass /swelling of relatively short duration with signs and symptoms depending on the site of the tumor ranging from asymptomatic to nonspecific respiratory symptoms, fever, or pain. The underlying cause of IMTs is poorly understood. IMTs are classified as tumours with an intermediate biological potential, in that local recurrences may occur and there is a rare possibility of distant metastasis. IMT is always in debate about its inflammatory origin or being a tumour, and also is benign or malignant and also regarding the adjuvant treatment. Despite the pathologic findings and their apparent prognostic implications, most affected individuals, regardless of the primary site, have had favorable clinical outcomes. Here a case of a primary stomach IMT in an adult man is presented with a review of the literature.